Regulatory evaluation of biosimilars throughout their product life-cycle
Sign Up to like & getrecommendations! Published in 2018 at "Bulletin of the World Health Organization"
DOI: 10.2471/blt.17.206284
Abstract: Abstract The World Health Assembly in 2014 adopted a resolution that recognized the importance of increasing access to biotherapeutic products, of improving their affordability and of ensuring their quality, safety and efficacy. Biosimilars are biotherapeutic… read more here.
Keywords: life cycle; biosimilars throughout; product life; life ... See more keywords